Poster Session 2

Presentations

P2.200

International master in donation and transplantation of organs, tissues and cells: A decade of evolution

Carmen Blanco (ES)

Bio Abstract

P2.201

Community based live kidney donation information sessions for potential renal transplant recipients and whānau: A community collaboration

Denise Beechey (NZ)

Bio Abstract

P2.203

Development of a low-cost 3D training model for vascular snastomosis in kidney transplantation: a technical report from a resource-limited setting

Deepesh Kenwar (IN)

Bio Abstract

P2.205

Building capacity for organ donation: a four-year follow-up of the ODISSeA training program

Mauricio Pereira (ES)

Bio Abstract

P2.206

Medical education fostering professionalism in organ donation involvement

Shunichi Yoshikai (JP)

Bio Abstract

P2.207

Experiences with AI-Based Proctored Online Examinations in E-learning Courses for Transplant Coordinators

Sunil Shroff (IN)

Bio Abstract

Presentations

P2.212

Neonatal organ donation and post-transplant outcomes: a scoping review of current practices and evidence

Rebecca Barzegar (AU)

Bio Abstract

P2.213

Psychological assessment and motivations of potential donors within the first Australian uterine transplant trial

Finn Campion (AU)

Bio Abstract

P2.214

Long-term skeletal stability in face transplantation: A voxel-based CT analysis

Anandhini Narayanan (US)

Bio Abstract

P2.215

Noninvasive immune monitoring after whole-eye transplantation using tear proteomics

Anandhini Narayanan (US)

Bio Abstract

P2.216

The perspectives of patients on vascularized composite allotransplantation: a systematic review and thematic analysis

Anita Van Zwieten (AU)

Bio Abstract

P2.217

Development of knock-in porcine cell lines expressing human immune genes under endogenous promoters for xenotransplantation

Dong Eon Kim (KR)

Bio Abstract

P2.218

Fabrication and Functional Validation of Parathyroid Organoids for Xenotransplantation in Non-Human Primates: Therapeutic approaches to hypoparathyroidism

Eun Yeol Yang (KR)

Bio Abstract

P2.219

CD40–CD154 costimulation blockade enables safe repeated xenotransfusion of genetically engineered porcine red blood cells in nonhuman primates

Hee Jung Kang (KR)

Bio Abstract

Presentations

P2.226

LL-37 ameliorates islet amyloid-induced glucose intolerance and β-cell dysfunction through inhibiting NLRP3 inflammasome activation in islet transplantation

Chen Cheng (CN)

Bio Abstract

P2.227

Pre-clinical model of intracutaneous biodegradable temporizing matrix as an alternate transplant site for human derived stem cells islets

Daniella Penko (AU)

Bio Abstract

P2.228

Therapeutic strategies to improve pancreatic islet cell viability for islet transplantation

Valentina Francesca Giai (GB)

Bio Abstract

P2.229

A novel mechanism of early pancreas allograft salvage after persistent duodenal leak

Amber Carrier (US)

Bio Abstract

P2.230

Long term outcomes with Belatacept use in pancreas transplantation

Pablo Uva (AR)

Bio Abstract

P2.232

When High Risk Isn’t So High: The Differential Impact of CMV D+/R− Mismatch in Solitary Pancreas Transplantation

Naim Issa (US)

Bio Abstract

P2.233

Hypocalcemia as an early surrogate marker of necrotizing pancreas allograft pancreatitis

Sumi Nair (US)

Bio Abstract

P2.236

Australia’s National Hereditary Pancreatitis Registry: A Platform for Identifying Candidates and Outcomes for Total Pancreatectomy with Islet Auto transplantation

James Zuiani (AU)

Bio Abstract

Presentations

P2.242

Case series of heart transplantation in advanced amyloid cardiomyopathy at a single centre

Breffny O'Shea (AU)

Bio Abstract

P2.243

Clinical relevance of donor derived cell free DNA (dd-cfDNA) levels in cardiac allograft monitoring: Does positive EMB vs. dd-cfDNA level predict different clinical outcome?

Felicity Lee (AU)

Bio Abstract

P2.244

Posttransplant dialysis in donation after circulatory death vs brain death heart transplantation - a 10yr analysis

Katherine Wang (AU)

Bio Abstract

P2.245

Diabetes and microalbuminuria in heart transplant recipients – insights from baseline characteristics of the Empagliflozin in Heart Transplant (EMPA-HTx) trial

Lisa Raven (AU)

Bio Abstract

P2.246

Outcomes of cardiometabolic syndrome burden on survival, physical capacity and quality of life after heart transplantation

Maria Simonenko (RU)

Bio Abstract

P2.247

Bridge to transplantation strategy in pediatric patients by continuous-flow LVADs

Minoru Ono (JP)

Bio Abstract

P2.248

Higher HLA molecular mismatch load in heart transplant recipients bridged with temporary mechanical circulatory support predicts allograft dysfunction

Mohamed Elrefaei (US)

Bio Abstract

P2.249

Are beta-blockers safe early after heart transplantation?

Sakae Takenaka (US)

Bio Abstract

P2.251

The Role of Lactobacillus rhamnosus in Cardiac Transplant Rejection by Regulating the Activation Function of CD8+ TRM Cells via the mTOR-P70S6K Pathway

Xiaolong Miao (CN)

Bio Abstract

P2.252

Lung transplant referral practices in aotearoa New Zealand

Amy O'Brien (NZ)

Bio Abstract

P2.253

Impact of Delirium on long-term outcomes of lung transplant recipients

Moo Suk Park (KR)

Bio Abstract

P2.254

Impact of HLA compatibility in blood product transfusion on post-transplant sensitisation and outcomes following lung transplantation

Steven Hiho (AU)

Bio Abstract

P2.255

Physiotherapy management of potential organ donors: A retrospective clinical audit

Vincenzo Marzano (AU)

Bio Abstract

P2.256

Impacts on short-term mortality with possible donor-derived infection in lung transplantation: A single-center retrospective study in China

Wenjie Hua (CN)

Bio Abstract

P2.257

China lung transplantation report 2015-2024: Current status and chinese characteristics

Wenjie Hua (CN)

Bio Abstract

P2.258

Echocardiographic recovery of right-heart load after lung transplantation in pulmonary hypertension: A retrospective cohort study

Zhenhang Dai (CN)

Bio Abstract

P2.259

Improved Early Lung Transplant Outcomes with Extended Ischemia Times using a 10°C Preservation Method A Single-Center Retrospective Cohort Study

Zitao Wang (CN)

Bio Abstract

P2.260

Pseudomonas Aeruginosa Colonization Drives Epithelial-Mesenchymal Transition in Chronic Lung Allograft Dysfunction via Macrophage-Derived THBS-1

Zitao Wang (CN)

Bio Abstract

P2.261

Patient experience of weight change post heart or lung transplantation.

Yu Han Natalie Kok (AU)

Bio Abstract

Presentations

P2.266 (P3.509 in Journal)

Liver Transport for Transplantation in Autonomous Intelligent Packaging: A Preclinical Study

Victor Cruz (BR)

Bio Abstract

P2.267

Reconstruction of hepatic venous outflow and management of its complications using ex vivo liver resection and autotransplantation: A single-center experience

Tiemin Jiang (CN)

Bio Abstract

P2.269

Impact of early calcineurin inhibitor exposure on late recurrence of hepatocellular carcinoma after liver transplantation: A systematic review and meta-analysis

Jae Hyun Kwon (KR)

Bio Abstract

P2.270

Evolution of patient selection for HCC liver transplantation: Improved oncologic outcomes following adoption of Milan+1 criteria in a small-volume center

Jaehun Yang (KR)

Bio Abstract

P2.272

Validation of Metroticket 2.0 model in an Australian population

Lauren Tang (AU)

Bio Abstract

P2.273

Excellent long-term outcomes after liver transplantation for paediatric hepatic malignancies: A 20-year single-centre experience

Muhammad Muizz Abdul Manan (AU)

Bio Abstract

P2.274

Comparable outcomes between patients with and without HCC in a 5-year period

Björn Nashan (CN)

Bio Abstract

P2.275

Successful reversal of portal hypertensive bowel ischemia via TIPS in patients with extreme hyperlactatemia

Hyo Jung Ko (KR)

Bio Abstract

P2.276

Early-onset antibody-mediated rejection caused by De Novo HLA class II donor-specific antibody after ABO-compatible liver transplantation: A case report

Okjoo Lee (KR)

Bio Abstract

P2.280

Exceptional long-term survival after heterotopic auxiliary liver transplantation: The longest living patients reported in the literature

Sedat Yildirim (TR)

Bio Abstract

P2.281

Innovative venous outflow reconstruction as a feasible alternative for adult liver transplant recipients with absent inferior vena cava: A case series and technical report

Shuo Wang (CN)

Bio Abstract

P2.283

A retrospective study on application of biliary stents in adult liver transplantation

Zhongquan Sun (CN)

Bio Abstract

P2.285

Hydrogel-Based Cytokine Delivery Accelerates Liver Regeneration Following Partial Hepatectomy

Catalina Ortiz (US)

Bio Abstract

P2.286

Comparison of intraoperative blood loss between low and high central venous pressure groups in living donor hepatectomy

Chuluunbaatar Donkhim (MN)

Bio Abstract

P2.287

MSCT: Features of segmental venous outflow disorder and its effect on early volumetric adaptation of the graft in transplantation of the right lobe of the liver from a living donor

Elyorjon Turgunboev (UZ)

Bio Abstract

P2.288

Comparative analysis of robotic and laparoscopic donor hepatectomy following an initial robotic experience in a low volume center

Eun Jeong Jang (KR)

Bio Abstract

P2.290

Safely pushing the boundaries for living liver donors

Maren Schulze (DE)

Bio Abstract

P2.291

The application effect of intraoperative cell salvage in liver transplantation based on HCC and non-HCC populations: A systematic review and meta-analysis progress

Min Qiang (CN)

Bio Abstract

P2.292

Launching minimally invasive right donor hepatectomy in a low-volume center: A single surgeon's experience

Minho Shin (KR)

Bio Abstract

P2.293

Factors influencing liver regeneration after living donor hepatectomy: A retrospective study in a small-volume center

Minjae Kim (KR)

Bio Abstract

P2.295

Impact of recipient BMI on the prediction of 1-year allograft function in living donor kidney transplantation

Pooja Budhiraja (US)

Bio Abstract

P2.296

Portal flow modulation in living donor liver transplantation

Serik Tileuov (KZ)

Bio Abstract

P2.297

Postreperfusion syndrome in liver transplantation: Revised diagnostic criteria incorporating pulmonary artery pressure and mixed venous oxygen saturation

Suk Hyung Choe (KR)

Bio Abstract

P2.299

Machine Learning–Based Identification of Perioperative Determinants of Clinically Relevant Small-for-Size Syndrome With Ferritin-Based Outcome Stratification After Adult Living Donor Liver Transplantation

Taiichi Wakiya (JP)

Bio Abstract

P2.300

Biliary stricture following living donor liver transplantation: Incidence, time to onset, and associated perioperative factors — A single-center experience from Mongolia

Tserenbat Bazarsad (MN)

Bio Abstract

P2.305

Dual living donor liver transplantation using two left lobe grafts: Simplified technique without bypass and vascular grafts

Yuji Soejima (JP)

Bio Abstract

P2.306

Preoperative vasoactive-inotropic score predicts early mortality after deceased donor liver transplantation

Do Hyun Kim (KR)

Bio Abstract

P2.307

Liver transplantation with extended-criteria brain-dead donors: Initial retrospective experience from a single Vietnamese center

Nghia Nguyen Quang (VN)

Bio Abstract

P2.308

Atopic diseases in children after liver transplant: A single centre experience

Norashikin Mohd Ranai (MY)

Bio Abstract

P2.309

De novo malignancies after liver transplantation in a small-volume center

Seong-Hwan Chang (KR)

Bio Abstract

P2.310

De novo malignancy post liver transplantation at Juntendo University Hospital

Yoshihiro Hirata (JP)

Bio Abstract

P2.311

Analysis of the extubation time in LDLT surgery at First Central Hospital of Mongolia

Bazarragchaa Regjii (MN)

Bio Abstract

P2.312

Liver transplantation outcomes in patients with secondary biliary cirrhosis following bile duct injury

Eduardo Massabki (BR)

Bio

P2.313

Sex-Related Differences in Intestinal Injury after Brain Death Rats

Cristiano de Jesus Correia (BR)

Bio Abstract

P2.314

Prognostic implications of donor-recipient sex mismatch in liver transplantation: A systematic review and meta-analysis

Shiwen Yang (CN)

Bio Abstract

P2.315

Portal inflow modulation by splenectomy for portal hyperperfusion improves outcomes after adult split liver transplantation: A multicenter retrospective cohort study

Zhiwei Li (CN)

Bio Abstract

P2.316

Renal function and new-onset post-transplant diabetes mellitus in liver transplant patients up to five years after transplantation

Apostolia Zolota (GR)

Bio Abstract

P2.317

Perioperative correlation of rotational thromboelastometry and conventional coagulation tests in liver transplant recipients: A retrospective analysis

Bayalagmaa Khuvtsagaan (MN)

Bio Abstract

P2.318

Liver transplantation outcomes in patients with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)

Dimitri A. Raptis (SA)

Bio Abstract

P2.320

Expanding regional experience with MNGIE: Clinical, transplant and genetic insights from 15 saudi patients

Ehab Abufarhaneh (CA)

Bio Abstract

P2.321

Establishing a High-Performance Liver Transplant Program in a Public Hospital: Fourteen-Year Outcomes and Expanding Access in a Resource-Limited Setting

Jaewon Lee (KR)

Bio Abstract

P2.322

Evolution of a high-volume liver transplant center in Central Europe: machine perfusion, complex graft strategies, oncologic transplantation, and adult living donation, 2026

Maciej Krasnodebski (PL)

Bio Abstract

P2.323

Liver transplantation for unresectable Colorectal Liver Metastases using expanded criteria deceased donor pool organs: First experience of a single centre in Argentina

Manuel Baravalle (AR)

Bio Abstract

P2.326

Liver steatosis quantification using artificial intelligence

Seigo Nishida (US)

Bio Abstract

P2.327

Restoration of functional brain network topology after liver transplantation in patients with liver cirrhosis

Yong Kyu Chung (KR)

Bio Abstract

Presentations

P2.330

A simple risk score using underlying disease and HLA-DRB1 mismatch predicts early T cell–mediated rejection after liver transplantation

Ryo Ataka (JP)

Bio Abstract

P2.331

Trends and predictors of keratinocyte cancers in organ transplant recipients: Insights from trends of skin cancer numbers in solid organ transplant recipients, the TOSCANI cohort study

Anne Tseng (AU)

Bio Abstract

P2.332

Angioimmunoblastic T-cell lymphoma post kidney transplant – A rare form of post-transplant lymphoproliferative disorder

Brady Thomson (AU)

Bio Abstract

P2.333

Trends in the cumulative incidence of keratinocyte cancers among solid organ transplant recipients

Cody Frear (AU)

Bio Abstract

P2.334

Safety and Immunogenicity of Recombinant Zoster Vaccine for Dialysis and Transplant Recipients

Lachlan Paparella (AU)

Bio Abstract

P2.336

Porto-Sinusoidal Vascular Disorder (PSVD) Associated with Tacrolimus in a Kidney Transplant Recipient

Thidarat Kitrungphaiboon (TH)

Bio Abstract

P2.337

Induction immunosuppression with anti-T lymphocyte globulin (GrafalonR) demonstrates low rates of EB viremia (EBV) and PTLD, and excellent graft survival and rejection profiles in pediatric kidney transplant recipients

Marwa Mohamed (US)

Bio Abstract

P2.339

Early Postoperative Next-Day Tacrolimus Trough Prediction After Kidney Transplantation Using a Missingness-Aware Gated Recurrent Unit Model: A Multicenter Nationwide Study

Ahram Han (KR)

Bio Abstract

P2.340

Diabetes mellitus is associated with long-term worsening of eGFR in kidney transplant recipients. Should the long-term use of diabetogenic medications, such as tacrolimus, be reconsidered?

Alain Assounga (ZA)

Bio Abstract

P2.341

Protocolised reduction of mycophenolate dose in Scottish kidney transplant recipients aged ≥60 years

Alessandra Orsillo (AU)

Bio Abstract

P2.342

Immunosuppressive drugs and calcium supplementation may be coadministered in kidney transplant recipients

Anders Asberg (NO)

Bio Abstract

P2.345

Higher tacrolimus concentration-to-dose ratio (C0/D Ratio) is associated with improved kidney function in kidney transplant recipients (KTRs) – A retrospective cohort study

Hon Shen Png (MY)

Bio Abstract

P2.346

Everolimus-based reduced tacrolimus immunosuppression in kidney retransplant recipients: A preliminary clinical experience

Junji Uchida (JP)

Bio Abstract

P2.347

Mechanistic Analysis and Therapeutic Efficacy of Prednisolone for Calcineurin Inhibitor-Induced Nephrotoxicity

Kazuhiro Ujihashi (JP)

Bio Abstract

P2.348

Induction with very low dose anti thymocyte globulin in renal transplantation; An effective, safe and economical solution

Khawar Sultan (PK)

Bio Abstract

P2.349

Steroid avoidance and withdrawal in kidney transplant recipients: a systematic review and meta-analysis

Laia Oliveras (ES)

Bio Abstract

P2.350

The influence of CYP3A5 genotype on tacrolimus pharmacokinetics and AUC/C0 ratio following conversion from twice-daily to once-daily formulation in kidney transplant recipients

Natavudh Townamchai (TH)

Bio Abstract

P2.351

Pharmacokinetic comparison of innovator and generic tacrolimus in kidney transplant patients receiving CYP3A boosters

Nuttasith Larpparisuth (TH)

Bio Abstract

P2.352

The impact of diarrhea on mycophenolate pharmacokinetics in kidney transplantation

Pamala Jacobson (US)

Bio Abstract

P2.353

Clinical predictor of BK virus clearance and the role of mTOR inhibitors in kidney transplant recipients: A Single-center experience

Peenida Skulratanasak (TH)

Bio Abstract

P2.354

Histological Resolution of GVHD-Associated Immune Complex Glomerulonephritis After JAK1/2 Inhibition with Ruxolitinib Following Allogeneic HSCT

Joanna Nathan (AU)

Bio Abstract

P2.355

Area under the curve-guided mycophenolate mofetil dose optimization in an ABO-incompatible Thai kidney transplant recipient with rare thrombocytopenia: A case report

Kunvadee Choochaeam (TH)

Bio Abstract

P2.356

Kidney transplantation in a patient with RNU4atacopathy

Maddison Taylor (AU)

Bio Abstract

P2.357

Development of a sampling-time error correction model for trough concentrations of extended-release tacrolimus in kidney transplant recipients

Cuiyu Zhong (CN)

Bio Abstract

P2.358

Impact of early tacrolimus exposure, therapeutic drug monitoring, and CYP3A5 genotype on short-term kidney transplant outcomes: A prospective single-centre cohort study from a lower-middle-income country

JEETA MAITY (IN)

Bio Abstract

P2.359

Pharmacogenetic profiling to optimise tacrolimus dosing: A single renal transplant centre experience

Sharon Ho (AU)

Bio Abstract

P2.360

Impact of CYP3A5 Expression on Clinical Outcomes in Renal Transplant Recipients Receiving Tacrolimus-Based Immunosuppression: A Retrospective Study from Central India

Sunny Malde (IN)

Bio Abstract

P2.361

Beyond CYP3A5: Extensive tacrolimus dosing variability in a multi‑ethnic southeast asian kidney transplant population

Zi Yun Chang (SG)

Bio Abstract

P2.362

Efferocytosis induces antigen-specific transplant tolerance via Treg and TGF-β

Masayuki Fujino (JP)

Bio Abstract

P2.363

Donor MHC-encoding mRNA combined with rapamycin induces donor antigen-specific immune suppression

Naoto Nishida (JP)

Bio Abstract

P2.364

The impact of tacrolimus formulation, conversions in formulation, and social deprivation on variability, time in therapeutic range, and healthcare utilization

David Taber (US)

Bio Abstract

Presentations

P2.366

A retrospective analysis of en-bloc dual kidney transplantation (DKT) versus single kidney transplantation (SKT) from < 5 years old paediatric donors - A single center experience

Abhilash Tirkey (IN)

Bio Abstract

P2.367

case series: Ex-vivo repair of saccular renal artery aneurysms from living and deceased donors

Abhinay Subramaniam (AU)

Bio Abstract

P2.368

Safety and feasibility of simultaneous laparoscopic bilateral nephrectomy for massive ADPKD kidneys during kidney transplantation a single center experience

Aisha Asiri (SA)

Bio Abstract

P2.370

Minimising secondary warm ischaemia in kidney transplantation: An international survey of current practice and attitudes toward standardisation

Amy Hort (AU)

Bio Abstract

P2.371

Kidney Transplantation with Duplicated Ureters: A Systematic Review and Meta Analysis

Nicholas Hegyi (AU)

Bio Abstract

P2.372

Transitioning from open to robot assisted kidney transplant - Our experience with first 21 cases

Anu Ramesh (IN)

Bio Abstract

P2.373

Robotic assisted Kidney Transplantation Without Regional Hypothermia: A Pilot Study of 10 Recipients Evaluating Feasibility and Early Outcomes.

Bipin Pal (IN)

Bio Abstract

P2.374

Robotic kidney transplantation without regional hypothermia versus conventional open kidney transplantation: A Propensity Score Matched Analysis of Outcomes

Bipin Pal (IN)

Bio Abstract

P2.375

A prospective cohort study on the perioperative outcomes of prophylactic drain placement versus no drain in kidney transplantation

Biswajit Deka (IN)

Bio Abstract

P2.378

Comparison of Midline and Rutherford Morrison Incisions in Renal Transplantation: Early Postoperative Complications within 90 days

Ela Curic (AU)

Bio Abstract

P2.379

Minimal incision kidney transplantation: a safe, effective, and aesthetically superior alternative to conventional techniques – a propensity-matched comparative study

Aisha Asiri (SA)

Bio Abstract

P2.381

Robot-assisted kidney transplantation in obese and non-obese recipients: A comparative analysis of perioperative and early functional outcomes

Harsh Bagla (IN)

Bio Abstract

P2.383

Optimal techniques for managing lower polar arteries in kidney transplantation: A comparative analysis of surgical approaches

Bolatbek Baimakhanov (KZ)

Bio Abstract

P2.384

Minimally invasive kidney transplantation via mini-pfannenstiel incision

Jongwon Ha (KR)

Bio Abstract

P2.385

Advancing robot assisted kidney transplant(RAKT) techniques to mimic open kidney transplant(OKT): Experience from a large volume kidney transplant centre

Anant Kumar (IN)

Bio Abstract

P2.386

Clinical outcomes of living donor robotic-assisted kidney transplantation in the Philippines

Katherine Ruth Relato (PH)

Bio Abstract

P2.387

External iliac artery dissection during living donor renal transplantation: Successful intraoperative management and graft preservation – A case report

Lauro Gabriel Noel (PH)

Bio Abstract

P2.389

Paediatric en bloc kidney transplantation: A 30-year single-centre experience

Matipaishe Mashayamombe (AU)

Bio Abstract

P2.390

Robot-assisted treatment of ureteral complications after kidney transplantation

Mireia Musquera (ES)

Bio Abstract

P2.391

Impact of intraoperative ureteral catheter placement on urological complications after living donor kidney transplantation

Mitsuru Tomizawa (JP)

Bio Abstract

P2.394

Early outcomes of robotic-assisted living donor renal transplantation: Initial, experience from a high-volume tertiary care centre in India

Om Prakash (IN)

Bio Abstract

P2.395

Robotic live-donor kidney transplantation: Technical nuances and early outcomes (Video Demonstration)

Om Prakash (IN)

Bio Abstract

P2.396

Comparative analysis of vascular reconstruction techniques for multiple renal arteries in kidney transplantation: A single-center experience

Onkar Suryawanshi (IN)

Bio Abstract

P2.397

Using angioembolisation to decrease morbidity prior to pediatric en-bloc kidney transplant graft nephrectomy implanted via the Newcastle technique

Rohit Sethi (AU)

Bio Abstract

P2.401

Functional Preservation of the Donor Perirenal Fat Capsule and Its Effect on Early Recovery After Kidney Transplantation: A Retrospective Cohort Study

Chao Yang (CN)

Bio Abstract

P2.407

Normothermic machine perfusion to facilitate right liver lobe utility

Georgina Riddiough (GB)

Bio Abstract

P2.409

Complex vascular outflow reconstruction and portal flow modulation in living donor liver transplantation. Right lobe graft. Open approach in a patient with primary sclerosing cholangitis (PSC)

Silvana Montal (AR)

Bio Abstract

P2.410

Middle hepatic vein reconstruction using recipient middle hepatic vein transposition in living donor liver transplantation involving right lobe grafts

Kazushige Migita (JP)

Bio Abstract

P2.411

Glissonian Wrapping Anastomosis for Biliary Reconstruction in Living Donor Liver Transplantation: A Novel Approach for Multiple Ducts with Wide Separation

Manuel Lim (KR)

Bio Abstract

P2.412

Laparoscopic-Assisted Explant Hepatectomy and Rotational Cavocaval Anastomosis for Liver Transplantation in Situs Inversus Totalis

Qi Can (CN)

Bio Abstract

P2.413

A simple technical modification to reduce bile leakage: Intra-anastomotic double-J stent placement in liver transplantation and complex biliary reconstruction

Sedat Yildirim (TR)

Bio Abstract

P2.415

The Branch Patch Technique for Arterial Anastomosis in Living Donor Liver Transplantation: Maintaining Favorable Outcomes in Small-Caliber Vessels

Tokuyuki Yamashita (JP)

Bio Abstract

P2.416

Ex vivo liver resection and autotransplantation for hepatic alveolar echinococcosis with cavernous transformation of the portal vein

Tuergan Aji (CN)

Bio Abstract

P2.417

Explainable machine learning for predicting early allograft dysfunction in Ex vivo liver resection and autotransplantation

Yingmei Shao (CN)

Bio Abstract

P2.419

Hybrid Colonic Grafting in a Miniature Swine Model

Hironori Kudo (JP)

Bio Abstract

P2.420

Minimal invasive crescentic incision for living donor nephrectomy: Long-term surgical and patient-reported outcomes

Adem Safak (TR)

Bio Abstract

Presentations

P2.425

A case of false four DRB1 alleles test from a patient with liver cirrhosis

Hyewon Park (KR)

Bio Abstract

P2.426

Research Gaps and Emerging Priorities in Liver Transplantation: A Systematic Landscape Analysis of Clinical Trials and Published Literature, 2000–2025

Jeong-Moo Lee (KR)

Bio Abstract

P2.427

Survey of ISODP 2025 Attendees on Donor Family Support Following Deceased Organ Donation

Miho Shingu (JP)

Bio Abstract

P2.428

Analysis of Family Refusal Reasons for Brain-Dead Organ Donation in Korea and International Comparison

Myoungkyun Seo (KR)

Bio Abstract

Presentations

P4.714 (401.2 in the journal)

An AAV-Mediated Murine Model for the Study of ABO-Incompatible Kidney Transplantation

Jiang Zhang (CN)

Bio Abstract

P4.715

Clinical outcome, prognosis, and risk predictors for severe pneumonia in ABO-incompatible kidney transplant recipients with pulmonary infection: A retrospective cohort study

Xuqin Jiang (CN)

Bio Abstract

P4.716

Graft outcomes of ABO incompatible-KTs are superior to those of ABO compatible-KTs over a follow-up of 15 years: Single center experiences

Dongryeol Lee (KR)

Bio Abstract

P4.717

The efficacy and safety of single-dose eculizumab combined with conventional preconditioning in ABO-incompatible renal transplantation with high baseline isoagglutinin titers

Jian Zhang (CN)

Bio Abstract

P4.718

Individualized fluid management in the early post-kidney transplant period: a case series from Indonesia

Mirna Praptini (ID)

Bio Abstract

P4.719

Improved antibody assessment for ABO-incompatible transplantation: Multiplex bead immunoassay increases eligibility compared to hemagglutination method in a single center study

Mohamed Elrefaei (US)

Bio Abstract

P4.720

ABO Incompatibility Living Donor Kidney Transplant in Malaysia: Multicenter Experiences and Outcomes

Premila Peraba (MY)

Bio Abstract

P4.721

Successful ABO-incompatible living donor kidney transplantation overcoming an extreme baseline isoagglutinin titer of 1:4096: A case report

Salin Wattanatorn (TH)

Bio Abstract

P4.722

Clinical outcomes across induction strategies in ABO-Incompatible kidney transplantation: A real-world analysis

Woo Yeong Park (KR)

Bio Abstract

P4.723

Comparative effectiveness and safety of denosumab versus bisphosphonates for osteoporosis in kidney transplant recipients

Woo Yeong Park (KR)

Bio Abstract

P4.724

Clinical characteristics of pulmonary infection in ABO-incompatible kidney transplantation recipients and risk factors for pulmonary infection and mortality: A retrospective study

Xuqin Jiang (CN)

Bio Abstract

P4.725

Microbiota-Derived S-adenosylmethionine regulated macrophage metabolic reprogramming in antibody-mediated rejection after kidney transplantation

Bin Ni (CN)

Bio Abstract

P4.726

Integrating HLA molecular mismatch and recipient T follicular helper genetic variants improves prediction of De Novo donor-specific antibodies after kidney transplantation

Hidetoshi Shidahara (JP)

Bio Abstract

P4.729

Characteristics of de novo donor-specific anti-HLA antibodies associated with graft fibrosis progression in adult living donor liver transplantation

Ryoichi Goto (JP)

Bio Abstract

P4.730

Mincle facilitates kidney allograft antibody-mediated rejection

Zijie Wang (CN)

Bio Abstract

P4.733

Comparative Outcomes of Kidney Transplantation in Elderly Versus Younger Recipients: A 7-year Retrospective Cohort Study in a Nigerian Transplant Center.

Kudirat Busari (NG)

Bio Abstract

P4.734

Clinical Outcomes of Anti-Thymocyte Globulin Versus Interleukin-2 Receptor Antagonists for Induction of Immunosuppression in Elderly Kidney Transplant Recipients: A Systematic Review and Meta-Analysis

Nicolas Vendeville (CA)

Bio Abstract

P4.735

Age-dependent causes of graft loss over three decades of kidney transplantation

Yoichi Kakuta (JP)

Bio Abstract

P4.736

Quantifying functional nephron mass mismatch using donor inulin clearance predicts graft loss after living donor kidney transplantation

Yoichi Kakuta (JP)

Bio Abstract

P4.737

Impact of tacrolimus trough intra-patient variability on donor-derived cell-free DNA and clinical outcomes

Robert Woodward (US)

Bio Abstract

P4.738

A retrospective cohort observational study of the bedside experience of the use of molecular microscope diagnostic system and the prospera donor-derived cell-free DNA assay in the interpretation and management of histopathological kidney transplant biopsy reports at the Singapore General Hospital

En Han Koh (SG)

Bio Abstract

P4.739

The Usefulness of Point-of-Care Ultrasound in Outpatient Surveillance During the First Year After Kidney Transplantation

Fernando Girón Luque (CO)

Bio Abstract

P4.740

Analytical verification of i-STAT CHEM8+ using finger-prick capillary whole blood in stable adult kidney transplant recipients

Fernando Girón Luque (CO)

Bio Abstract

P4.742

Contrast enhanced ultrasound (ceus) correlation with biochemical parameters in kidney transplant recipients

Lucino Bahena Carrera (MX)

Bio Abstract

P4.746

A conceptual three hit framework for ureteral stenosis after kidney transplantation a systematic review and meta analysis

Firtantyo Adi Syahputra (ID)

Bio Abstract

P4.747

Outcomes of extended criteria deceased donor kidney transplants allocated by Remuzzi scoring of explant biopsies

Anantharaman Vathsala (SG)

Bio Abstract

P4.748

The newly synthesized fibrinogen mediated by SSBP1 during cold storage induces post-reperfusion severe erythrocyte aggregation and tubular injury in donation after cardiac death kidneys

Encheng Zhou (CN)

Bio Abstract

P4.749

Thirty-five years of ultra-long-term outcomes after kidney transplantation from cardiac death donors: A single-center experience in Japan

Hitomi Sasaki (JP)

Bio Abstract

P4.750

Deceased donor kidney transplantation: A single-center experience from Vietnam

Hoang Chuan (VN)

Bio Abstract

P4.751

Assessment of donor referrals and expansion of transplantation for HIV positive patients in kidney failure at Groote Schuur Hospital, South Africa.

Laurie Bertels (ZA)

Bio Abstract

P4.752

Expanding transplant boundaries: First dual-kidney transplant in the Dominican Republic

Mónica Buonpensiere (DO)

Bio Abstract

P4.753

Knowledge, Attitudes, and Barriers to Kidney Donation in Tunisia: Findings from a Public Awareness Event

Mouna Jerbi (TN)

Bio Abstract

P4.754

Clinical Significance of 5-Locus (A, B, C, DRB1, DQB1) HLA Eplet Mismatches in Predicting Biopsy-Proven Rejection among Deceased Donor Kidney Transplantation (DDKT) Recipients

Shinae Yu (KR)

Bio Abstract

P4.755

Donor?

Yigang Luo (CA)

Bio Abstract

P4.758

Body Image and Cosmesis among Living Kidney Donors in Rwanda

Emmanuel Muhawenimana (RW)

Bio Abstract

P4.759

Improving Efficiency and Increased Transplant Volume with Expansion of Multidisciplinary Living Donor Team at an Academic Transplant Center

Fanny Gallant (US)

Bio Abstract

P4.760

Integrating the Role of an Advanced Practice Provider in a Living Donor Program

Fanny Gallant (US)

Bio Abstract

P4.762

The relationship between preoperative cyberchondria levels and surgical fear of kidney donors

Filiz Öğce Aktaş (TR)

Bio Abstract

P4.763

Impact of Cold and Warm Ischemic Time on Three-Month Allograft Function in Kidney Transplant Recipients: A Single-Center Retrospective Cohort Study

Ghea De Silva (ID)

Bio Abstract

P4.764

Functional Recovery Precedes Structural Hypertrophy After Living Kidney Donation: Evidence of Temporal Dissociation

Hajime Hirano (JP)

Bio Abstract

P4.765

A rare case of bk polyomavirus associated nephropathy in a recipient kidney transplantation: A clinical challenge in nephrology internal medicine

Indah Elyani (ID)

Bio Abstract

P4.766

Determinants of follow-up adherence in living kidney donors: the role of donor–recipient relationship

Jihye Huh (KR)

Bio Abstract

P4.767

Development and Validation of eGFR Prediction Model After Living Kidney Donation: single center 10-fold cross validation model

Jinsoo Rhu (KR)

Bio Abstract

P4.768

Impact of Donor Renal Function and Age on Outcomes in Living Donor Kidney Transplantation: A Retrospective Multicenter Study in Japan

Kazuaki Yamanaka (JP)

Bio Abstract

P4.770

Short-term kidney transplant outcome of recipients at a super-specialised kidney centre in north-central Nigeria: A 5-year retrospective study

Kudirat Busari (NG)

Bio Abstract

P4.772

Equine antithymocyte globulin versus Basiliximab for induction immunosuppression in living donor kidney transplantation: efficacy safety and feasibility in low resource setting

Chanaka Hitthara Gedara Abeyrathne (LK)

Bio Abstract

P4.773

Trends in kidney transplantation in the Philippines: A 5-year database analysis

Mark Lenon Tulisana (PH)

Bio Abstract

P4.774

Donor sex influences early kidney allograft function: a retrospective cohort study from Indonesia

Nicolaus Lempan Palimbong Rungngu (ID)

Bio Abstract

P4.775

Determinants of Early Renal Function Decline Following Living-Related Kidney Donation: A Retrospective Cohort Study from Nigeria

Olalekan Olatise (NG)

Bio Abstract

P4.776

Renal vascular disparities among kidney donors, a reterospective study.

Rashid Hamid (PK)

Bio Abstract

P4.777

Kidney transplantation without commercial factors: A series of 100 cases at HCMC university of medical center (UMC), Vietnam

Sinh Tran (VN)

Bio Abstract

P4.778

A 25-year analysis of renal and metabolic trajectories in living kidney donors

Sirilak Rakchaiyaphum (TH)

Bio Abstract

P4.779

First living donor renal transplantation of a HIV positive patient from a HIV positive donor in Southeast Asia: Changing paradigms in modern medicine

Sobhana Thangaraju (SG)

Bio Abstract

P4.781

The potential benefits of preemptive kidney transplantation: Reduced rates of cerebro-cardiovascular events and neoplasm development

Tomoko Hamaya (JP)

Bio Abstract

P4.784

EBV viremia and PTLD incidence in EBV-negative kidney transplant recipients: Alemtuzumab vs. Basiliximab induction

Hasan Khamash (US)

Bio Abstract

P4.785

Anastomosing hemangioma masquerading as renal cell carcinoma in a transplanted kidney

Soo Jin Na Choi (KR)

Bio Abstract

P4.786

Late onset de novo malignancy after kidney transplantation in a five decade two center cohort

Tsuyoshi Matsuda (JP)

Bio Abstract

P4.787

Metabolic benefits of GLP-1RA and SGLT2i use after kidney transplantation: A single center real-world experience

Archana Sadhu (US)

Bio Abstract

P4.788

Analysis of factors associated with intraoperative metabolic acidosis and delayed graft function in kidney transplantation

Bin Liang (CN)

Bio Abstract

P4.789

Long-term changes in hypertension and body mass index after kidney transplantation: A five-year cohort study

Dat Nguyen (VN)

Bio Abstract

P4.790

Efficacy and safety of tirzepatide for weight reduction in kidney transplant recipients

Fatima AlKindi (AE)

Bio Abstract

P4.791

Osteoporosis treatment patterns and bone mineral density response in kidney transplant recipients: A single-center retrospective study

Kenta Futamura (JP)

Bio Abstract

P4.792

Dynamic impact of post-transplant serum magnesium levels on graft outcomes in kidney transplantation: A retrospective cohort study

Meng Zhang (CN)

Bio Abstract

P4.793

Metabolic-dysfunction associated fatty liver disease and compensated advanced chronic liver disease among kidney transplant recipients in Malaysia

Min Yie Lim (MY)

Bio Abstract

P4.794

Posttransplant diabetes mellitus (PTDM) frequency, risk factors, and outcomes: A single-center experience

Muhammad Tassaduq Khan (PK)

Bio Abstract

P4.795

Study on the role of adipose tissue endoplasmic reticulum stress and monocyte chemoattractant protein-1 in tacrolimus induced new onset diabetes after renal transplantation

Qinghai Wang (CN)

Bio Abstract

P4.796

Early changes in parameters of chronic kidney disease mineral and bone disorder after kidney transplantation

Taehyun Ban (KR)

Bio Abstract

P4.797

Kidney transplantation in proliferative glomerulonephritis with monoclonal immune deposits (pgnmid): a case series

Allison Webber (US)

Bio Abstract

P4.798

C3G After Transplant: An Underrecognized Challenge

Claudia César de Albuquerque (BR)

Bio Abstract

P4.799

Discontinuation of Eculizumab after kidney transplantation in pediatric aHUS: Is it safe? A multicenter cohort study

Patimat Gadzhieva (RU)

Bio Abstract

P4.800

Graft outcomes in biopsy-proven recurrent IgA nephropathy after kidney transplantation: Rare but clinically meaningful

Pitchamon Inkong (US)

Bio Abstract

P4.802

Spectrum of De novo focal segmental glomerulosclerosis in renal allografts: A 15 year single centre experience

Ridam Shrinesh Agrawal (IN)

Bio Abstract

P4.803

Recurrent light chain-restricted PGNMID after kidney transplantation

Sumedh Jayanti (AU)

Bio Abstract

P4.804

Perspectives of transplant clinicians on the detection and management of acute rejection in kidney and simultaneous pancreas-kidney transplant recipients - A semi-structured interview study

Chandana Guha (AU)

Bio Abstract

P4.805

Low-dose daratumumab therapy for antibody-mediated rejection in kidney transplantation: a single-center experience

Gabriele Mortari (IT)

Bio Abstract

P4.806

Clinical impact of non-HLA antibodies in Thai kidney transplant recipients with antibody-mediated rejection

Gahwin Ruchikajorndech (TH)

Bio Abstract

P4.807

A case of severe mixed rejection after a living kidney transplant with a cadaveric donor vein

Saskia Leibowitz (AU)

Bio Abstract

P4.808

A case of IgA nephropathy recurrence after kidney transplantation possibly related to COVID-19 infection

Saskia Leibowitz (AU)

Bio Abstract

P4.809

CMV transplant nephritis and graft failure: A cautionary tale

Sami Alasfar (US)

Bio Abstract

P4.810

Donor APOL1 high-risk genotypes and early graft failure: Two cases of De Novo collapsing FSGS with second hits

Sami Alasfar (US)

Bio Abstract

P4.811

Characteristics of patients on the waiting list for kidney transplantation for more than five years

Apostolia Zolota (GR)

Bio Abstract

P4.812

Renal Wedge Biopsies: Are We Doing More Harm than Good?

Chris Jaynes (US)

Bio Abstract

P4.814

Percutaneous treatment of ureteral complications after kidney transplantation: High success rates and long-term graft preservation

Fatih Boyvat (TR)

Bio Abstract

P4.815

Evaluation of growth patterns following pediatric kidney transplantation

Henny Puspitasari (ID)

Bio Abstract

P4.817

Cost of kidney transplantation in Zambia, Africa: A comparative analysis of local and overseas access models

Maha Mohamed (US)

Bio Abstract

P4.819

Complement C5 inhibition after kidney transplantation – A national single-center experience from Slovenia

Špela Borštnar (SI)

Bio Abstract

P4.820

Application of artificial intelligence (AI) in organ allocation from deceased donors at Cho Ray hospital: The first steps

Thu Du (VN)

Bio Abstract

P4.822

A case report: Adenovirus nephritis with BK nephropathy after deceased donor kidney transplantation

Yanghyeon Kim (KR)

Bio Abstract

P4.823

Correlation of tacrolimus concentrations with AUC according to C/D ratio–based metabolizer status in kidney transplant recipients

Young Ju Oh (KR)

Bio Abstract

P4.824

Comprehensive longitudinal assessment of renal function in living kidney donors: Comparison of eGFR, creatinine clearance, and inulin clearance

Yuichi Machida (JP)

Bio Abstract

P4.825 (P3.586 in the journal)

Primary keratinocyte skin cancer Electrochemotherapy efficacy: a systematic review and meta-analysis

Brenda Maria Rosales (AU)

Bio Abstract

P4.826 (P3.686 in the journal)

Urinary ascites after kidney transplant: An unusual cause of rapid abdominal distension and rising creatinine

Arsh Desai (IN)

Bio Abstract

Presentations

P4.835

Financial burden and coping strategies in transplant patients in a single centre in India

Deepesh Kenwar (IN)

Bio Abstract

P4.836

Attitudes toward organ donation among individuals with and without transplantation experience: A cross-sectional study from Libya

Ehtuish Ehtuish (LY)

Bio Abstract

P4.837

Racial/ethnic disparities in pediatric allocation priority in kidney transplantation

Justin Steggerda (US)

Bio Abstract

P4.839

Cognition of organ transplantation administration and regulations: A key mediating mechanism for the willingness gap in organ donation between Chinese and European youth

Xinchi Zhang (CN)

Bio Abstract

P4.840

Dental complications after kidney transplantation in patients with intellectual disability: A single-center experience

Lea Katalinic (HR)

Bio Abstract

P4.841

Factors Associated with Waiting Time for Deceased Donor Kidney Transplantation in Mexico: A Nationwide Registry Analysis

Eber Guajardo (MX)

Bio Abstract

P4.843

A qualitative study to determine reasons patients with end stage kidney disease refuse deceased donor kidney transplantation in Malaysia

Theeba Tinakarun (MY)

Bio Abstract

P4.844

Exploring influencing factors for the wrong decision from kidney and liver failure patients to accept organs donation from their relatives

Yaser Kattoah (SA)

Bio Abstract

P4.846

How the UAE’s Legal Framework is Driving a Model Organ Donation and Transplantation System in the Arab World

Maria Gomez (AE)

Bio Abstract

P4.847

Genetic Testing in Living Kidney Donors : Bridging guidelines, ethics and patient perspective

Sourya Mohakuda (IN)

Bio Abstract

P4.848

The impact of opt-in and opt-out consent policies on deceased donor transplantation rates before, during, and after the COVID-19 pandemic

Ruhul Kuddus (US)

Bio Abstract

P4.849

Global inequities in deceased donor organ transplantation: A comparative analysis of developing countries and high-income countries

Ruhul Kuddus (US)

Bio Abstract

P4.850

Medical management of Jehovah’s Witnesses requiring solid organ transplantation: A collaborative approach

Sean Cash (AU)

Bio Abstract

P4.851

Gender patterns within a closed loop path analysis of living kidney donation under the Taiwan five degree kinship restriction

Chin Yu Cheng (TW)

Bio Abstract

P4.852

Informing A Novel Strategy To Increase Access To Living Kidney Donor Transplantation For Women

Wanda Rojas (CA)

Bio Abstract

P4.854

Optimization of liver transplantation outcomes through inter-institutional collaboration: A novel consulting model

Jeong-Moo Lee (KR)

Bio Abstract

P4.856

Multi‑level determinants of post‑transplant outcomes in low‑resource settings: Insights from St. Paul’s Hospital Millennium Medical College

Mekdim Tadesse Siyoum (ET)

Bio Abstract

P4.857

Your donation saves lives: How comprehensive philanthropic funding transforms complex patient journeys in organ transplantation

Nujood AlKhloofi (AE)

Bio Abstract

P4.858

Pakistan Kidney and Liver Institute and Research Center (PKLI); Challenges of creating a transplant center in Low- and middle-income countries

Saeed Akhter (PK)

Bio Abstract

P4.859

The impact of decisions to withdraw life-sustaining treatment on organ donation in potential brain-dead donors: An 8-year empirical analysis (2018–2025)

Seung-Rye Jeong (KR)

Bio Abstract

Presentations

P4.864

Epigenetic reprogramming by maternal obesity drives trained immunity and MASLD development in offspring

Moonhyung Lee (KR)

Bio Abstract

P4.865

CH25H alleviates liver ischemia-reperfusion injury by regulating NOD2 palmitoylation-mediated membrane lipid remodeling

Tao Qiu (CN)

Bio Abstract

P4.867

Exploring the mechanism of low immunosuppression demand in polycystic kidney disease patients after kidney transplantation: The role of CD209+ macrophages

Difei Ren (CN)

Bio Abstract

P4.868

Spermine promotes thymic regeneration in aged mice to increase naive T cell reconstitution and restore antibody-induced transplant tolerance

Gaoping Zhao (CN)

Bio Abstract

P4.869

IVIG induces paradoxical activation of monocyte-derived antigen-presenting cells in immunologically stable conditions

Masato Shizuku (JP)

Bio Abstract

P4.870

Mechanistic Study of SLC40A1-Mediated Iron Metabolism Reprogramming in Kupffer Cells for Neutrophils Recruitment in Liver Transplant Ischemia Reperfusion Injury

Jinzhen Cai (CN)

Bio Abstract

P4.871

Different Induction Strategies in Kidney Transplantation: A Comparative Analysis of Alemtuzumab, Alemtuzumab plus Eculizumab, and Basiliximab

Stanislav Shchekaturov (RU)

Bio Abstract

P4.875

Influence of CYP genetic polymorphism on tacrolimus pharmacokinetics in renal recipients: Evidence in kazakh population

Bolatbek Baimakhanov (KZ)

Bio Abstract

P4.876

From fixed dosing to AUC-guided monitoring: Optimizing mycophenolate mofetil therapy in kidney transplant recipients

Nuria Lloberas (ES)

Bio Abstract

P4.877

Attempt to minimize maintenance immunosuppressive therapy based on T and B cell epitope mismatch: Difference between PIRCHE-II and PIRCHE-T2

Takaaki Kobayashi (JP)

Bio Abstract

P4.878

Corticosteroids attenuate Tacrolimus-induced chronic nephrotoxicity via suppression of tubular NF-κB/STAT3 signaling: A mouse-to-human translational study

Tatsuya Hoshi (JP)

Bio Abstract

P4.879

Chimeric liver and immunosuppression withdrawal in long-term liver transplant recipients

Wei-Chen Lee (TW)

Bio Abstract

P4.883

Detection and management of Latent TB in kidney transplant candidates. A retrospective study.

Armelle Villalobos (CA)

Bio Abstract

P4.884

Safety and Outcomes of Kidney Transplantation Using Exceptional Distribution Increased-Risk Donors.

Armelle Villalobos (CA)

Bio Abstract

P4.885

Donor-derived HHV-8 causing multicentric Castleman disease with Kaposi sarcoma after kidney transplantation

Camille N. Kotton (US)

Bio Abstract

P4.886

PCR viral load thresholds corresponding to CMV antigenemia cutoffs in kidney transplant recipients

Kenta Futamura (JP)

Bio Abstract

P4.887

Early detection of CMV dnaemia identifies recipients at risk for poor early outcomes after liver transplantation

Kyeong Sik Kim (KR)

Bio Abstract

P4.888

Prevalence of persistent infections in pre-kidney transplant patients

Mónica Buonpensiere (DO)

Bio Abstract

P4.889

IgM-enriched intravenous immunoglobulin as adjunctive therapy in kidney transplant recipients with severe infections: A retrospective cohort study

Nikolina Basic-Jukic (HR)

Bio Abstract

P4.890

Clinical and Microbiological Risk Factors Associated with Histopathological Fungal Infection in Liver Transplant Explants: A Retrospective Cohort Analysis

Uta Merle (DE)

Bio Abstract

P4.891

Infections and surgical site complications following kidney transplantation: Risk factors and clinical implications

Valeria Ripa (US)

Bio Abstract

P4.892

SGLT2 inhibitors and the risk of urinary tract infections in kidney transplant recipients: A propensity score matched multicenter cohort study

Yoon Ju Kim (KR)

Bio Abstract

P4.895

Computational fluid dynamics modeling of donor liver cooling during hypothermic perfusion: Evidence for temperature gradient-driven heterogeneous ischemic injury

Bakhtiyar Kazymov (RU)

Bio Abstract

P4.899

Histone H4 lysine 12 lactylation drives METTL3 dependent N6 methyladenosine modification of PRDM15 to promote ferroptosis in renal ischemia reperfusion injury

Jiale Wang (CN)

Bio Abstract

P4.900

The efficacy of intraoperative dexmedetomidine on delayed graft function in patients receiving a kidney transplant: The KEYSTONE trial proposal.

Jonathan Bannard-Smith (GB)

Bio Abstract

P4.901

ERO1⁺ macrophage polarization drives hyperlactatemia-aggravated hepatic ischemia-reperfusion injury after liver transplantation

Lin Ji (CN)

Bio Abstract

P4.902

DRSAb targeting ATP1A1 inhibits ferroptosis in renal ischemia reperfusion injury by reguating ACSL4

Yixuan Li (CN)

Bio Abstract

P4.903

The usefulness of prebiotics-derived short-chain fatty acids in liver ischemia–reperfusion injury.

Yoichiro Uchida (JP)

Bio Abstract

P4.905

IDHP protects against renal ischemia-reperfusion injury through HMOX1/ferroptosis pathway

Chenguang Ding (CN)

Bio Abstract

P4.906

Lactylation-driven METTL3-mediated m6A modification of PCK1 aggravates tubular epithelial cell apoptosis in renal ischemia-reperfusion injury

Chenguang Ding (CN)

Bio Abstract

P4.911

🎗LEA29Y pigs facilitate a local break down of remodelling processes in post-ischemic myocardial scar formation under immunosuppression

Heinke Heymer (DE)

Bio Abstract

P4.912

Gut Metatranscriptome Pathways Associated with Mycophenolic Acid Pharmacokinetics in Kidney Transplant Recipients

Ajay Israni (US)

Bio Abstract

P4.913

Computational modeling of portal vein thrombosis after liver transplantation: A coupled navier-stokes / reduced coagulation cascade approach with quantum computing perspective

Boris Yaremin (RU)

Bio Abstract

P4.914

Gut microbiome stability across ABO compatibility in kidney transplantation: Longitudinal fecal microbiome and targeted metabolomics profiling

Jin-Myung Kim (KR)

Bio Abstract

P4.915

Single cell analysis reveals an NK2 driven monocyte interaction axis in antibody mediated rejection after kidney transplantation

Jin-Myung Kim (KR)

Bio Abstract

P4.916

APOE promotes fibrosis in DCD kidney transplantation by regulating macrophage lipid metabolism through the TREM2-PI3K/AKT pathway

Zibiao Zhong (CN)

Bio Abstract

P4.917

Region-Specific Mitochondrial Pathway Downregulation in BK Virus–Associated Nephropathy

Soie Kwon (KR)

Bio Abstract

P4.918

Methionine deficient high fat diet induces stress responsive reprogramming in hepatic ILC1 and NK cells and promotes tumor growth

Yoshitaka Saegusa (JP)

Bio Abstract

P4.919

Cytokine and cardiovascular proteomics identify circulating biomarkers of allograft rejection in heart transplantation

Zeying Du (US)

Bio Abstract

P4.920

Integrated evaluation of thermal stability and operational outcomes in abdominal organ transport using LifeSafe organ transport container

Saravan Kumar (US)

Bio Abstract

P4.921

Cytokines profile in donation after cardiac death with sequential NRP and ex situ MP

Daniele Pezzati (IT)

Bio Abstract

P4.922

First series of DCD multivisceral transplantation using NRP in children

Francisco Hernández Oliveros (ES)

Bio Abstract

P4.923

First Experience with Normothermic Machine Perfusion in Kazakhstan

Jamilya Saparbay (KZ)

Bio Abstract

P4.924

Surgeon perspectives and practice patterns of machine perfusion in liver transplantation in the United States

Justin Steggerda (US)

Bio Abstract

P4.925

Normothermic Machine Perfusion Attenuates Mitochondrial Injury in Rat Livers from Donated After Circulatory Death

Lin Fan (CN)

Bio Abstract

P4.926

Incorporating a Hepatic Bioreactor in Ex Vivo Lung Perfusion Enhances the Milieu of Lung Preservation

Pablo Sanchez (US)

Bio Abstract